ArticleClinical ophthalmology (Auckland, N.Z.)2012

Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study.

Ranjan Malhotra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.